Dyax Corp. (NASDAQ:DYAX) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Dyax Corp. (NASDAQ:DYAX) currently has a Zacks Rank #3 (Hold). Dyax Corp. (NASDAQ:DYAX) stock performance was 5.90% in last session and finished the day at $8.98. Traded volume was 3.39million shares in the last session and the average volume of the stock remained 1.42million shares. The beta of the stock remained 1.35. Dyax Corp. (NASDAQ:DYAX) insider ownership is 0.60%.

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Incyte Corporation (NASDAQ:INCY) was identified as having a larger market cap than the smaller end of the S&P 500, for example Molson Coors Brewing Co. (TAP_), according to The Online Investor. Incyte Corporation (NASDAQ:INCY) rose 7.17 percent to $53.52 Monday on volume of 2.25million shares. The intra-day range of the stock was $50.27 to $53.81. Incyte Corporation (NASDAQ:INCY) has a market capitalization of $8.86billion.

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) announced the final results from its Phase 2 study of ISIS-APOCIIIRx in patients with high to severely high triglycerides on stable doses of fibrates. In this study, patients treated with ISIS-APOCIIIRx achieved average reductions of up to 71 percent in apolipoprotein C-III (apoC-III) and up to 64 percent in triglycerides, and average increases of up to 52 percent in high-density lipoprotein cholesterol (HDL-C), the ‘good’ cholesterol. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)’s stock on Mar 31, 2014 reported a increase of 8.84% to the closing price of $43.21. Its fifty two weeks range is $15.92 -$62.66. The total market capitalization recorded $5.07billion. The overall volume in the last trading session was 2.32million shares. In its share capital, ISIS has 117.27million outstanding shares.

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13(th) Annual Needham Healthcare Conference in New York on Tuesday, April 8, 2014 at 8:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. On Monday, shares of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) advanced 5.87% to close the day at $29.93. Company return on investment (ROI) is -0.70% and its monthly performance is recorded as -14.44%. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) quarterly revenue growth is 0.88%.